INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: triple therapy targets tumors
Disease control Not yet recruitingThis study tests a new combination of drugs for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that cannot be removed by surgery. The treatment includes chemotherapy delivered directly to the liver, a targeted oral drug, and an immunotherapy. Th…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Modified virus takes on bile duct cancer in new trial
Disease control Not yet recruitingThis study tests a new treatment called VG2025 for people with advanced bile duct cancer that has spread. VG2025 is a modified virus designed to infect and kill cancer cells while boosting the immune system. The trial will enroll 30 adults to see if the treatment can shrink tumor…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated May 08, 2026 12:04 UTC